porphyrin-naphthoquinones (SLIL)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameporphyrin-naphthoquinones (SLIL)
Drug Alias NameSL-11154SL-11202SL-11145
ClassificationSmall molecules
Mechanisms of ActionDNA topoisomerase inhibitors
TargetsDNA topoisomerase
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSLIL Biomedical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSLIL Biomedical Corp
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A